№ files_lp_4_process_1_50096
File format: docx
Character count: 13555
File size: 84 KB
Clinical study report analyzing survival outcomes of ESCC patients with detailed statistical evaluation of multiple prognostic factors using Cox regression models and Kaplan–Meier survival curves.
Year:
2026
Region:
Not specified
Research Field:
Oncology
Document Type:
Clinical study report
Institution:
Not specified
Author:
Not specified
Target Population:
ESCC patients
Study Period:
Not specified
Data Analysis Methods:
Univariate and multivariate Cox regression, Kaplan–Meier survival curves, Chi-square test
Variables Analyzed:
Age, sex, tumor location, grade, T stage, stage, primary tumor length, tumor types, lymphatic invasion, perineural invasion, lymphangio vascular invasion, postoperative chemotherapy
Survival Outcomes:
Overall survival, stratified survival by stage, lymph node status, T stage, and chemotherapy
Statistical Significance Threshold:
p < 0.05
Sample Size:
195 patients
Follow-up:
Postoperative
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2014
Region / city:
India
Type of document:
Original research article
Field:
Oral and maxillofacial pathology
Authors:
R Syedmukith, BR Ahmedmujib, TS Bastian
Study period:
1997–2005
Sample size:
75 patients
Age groups:
≤40 years and >40 years
Follow-up duration:
5 years
Staging system:
STNMP (site, tumor, node, metastasis, pathology)
Conflict of interest:
None
Funding:
Nil
Year:
2022
Region / City:
N/A
Topic:
Oncology, Pathology
Document Type:
Protocol
Organization:
CAP (College of American Pathologists)
Authors:
Raja R. Seethala, MD; Wonwoo Shon, DO; Bonnie L. Balzer, MD, PhD; Umamaheswar Duvvuri, MD, PhD; Nima M. Gharavi, MD, PhD; William Lydiatt, MD
Intended Audience:
Pathologists, Clinical Laboratories, Medical Institutions
Effective Period:
From March 2023
Approval Date:
September 2022
Amendment Date:
N/A
Organization:
Society for Immunotherapy of Cancer
Document Type:
Bibliography
Subject:
Cancer Immunotherapy
Focus:
Head and Neck Squamous Cell Carcinoma
Publication Date:
December 17, 2018
Date Range of Literature Search:
December 1, 2013 – December 17, 2018
Search Limits:
Humans, Clinical Trial, Meta-Analysis, Practice Guideline, Randomized Controlled Trial, Review
Therapeutic Agents Covered:
Pembrolizumab, Nivolumab, Cemiplimab, Durvalumab
Biomarkers and Targets:
PD-1, PD-L1, HPV
Total References Identified:
199
Total Duplicates Removed:
42
Total Records in Bibliography:
157
Topics Included:
Immune checkpoint inhibitors, biomarkers, combination immunotherapy, adverse events, toxicity, vaccine, adjuvant and neoadjuvant immunotherapy, rare head and neck cancers
Year:
2023
Region / City:
Not specified
Topic:
Thoracic esophagectomy, survival outcomes, esophageal cancer
Document Type:
Research article
Institution:
Not specified
Author:
Not specified
Target Audience:
Medical professionals, researchers in oncology
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Patient Demographics:
70-year-old white male; 68-year-old black male
Primary Site:
Left pyriform sinus; Right lateral wall of oropharynx
Histology:
Squamous cell carcinoma, invasive
Grade/Differentiation:
Moderately to poorly differentiated
Clinical Stage:
cT2 cN2b cM0 Stage IVA; cT2 N2b M0 Stage IVA
Treatment:
Chemoradiation with cisplatin, 70 Gy in 35 fractions for pyriform sinus; 60 Gy in 30 fractions for oropharynx
Imaging:
CT Neck, PET/CT, CT Larynx/Neck
Surgical Procedures:
Fine needle aspiration, transoral resection, selective neck dissection
Lymph Node Status:
Metastatic involvement in cervical and retropharyngeal nodes
Perineural and Lymphovascular Invasion:
Present in oropharyngeal tumor
Smoking Status:
Current smoker (first patient), smoker (second patient)
Alcohol Use:
Current user (first patient), history of alcohol use (second patient)
HPV Status:
Positive (first patient)
Year:
2016
Region / city:
Seoul, Korea
Subject:
Medical research, Oncology
Document type:
Supplementary Methods
Organization / institution:
Seoul National University, Jackson Laboratory for Genomic Medicine, MD Anderson Cancer Center
Authors:
Yun-Suhk Suh, Deukchae Na, Ju-Seog Lee, Jeesoo Chae, EuiHyun Kim, Giyong Jang, Jieun Lee, Jimin Min, Chan-Young Ock, Seong-Ho Kong, Joshy George, Chengsheng Zhang, Hyuk-Joon Lee, Jong-Il Kim, Seong-Jin Kim, Woo Ho Kim, Charles Lee, Han-Kwang Yang
Target audience:
Researchers, medical professionals, academicians
Date of approval:
2016
Date of modifications:
None
Year:
2025
Region / City:
Maisons-Alfort, France
Subject:
Esophageal pathologies, pediatric surgery, biotherapy, genetics, minimally invasive surgery
Document Type:
Prize announcement and application guidelines
Organization:
Association Française de l’Atresie de l’Oesophage (AFAO)
Chairperson:
Viviane Armand
Deadline for Applications:
May 21, 2025
Announcement Date:
June 25, 2025
Presentation Date:
June 28, 2025
Funding Amount:
approximately €15,000 (depending on fundraising)
Eligibility:
Clinical and preclinical research projects on esophageal diseases
Evaluation Criteria:
Originality, feasibility, scientific quality, patient relevance
Required Compliance:
Regulatory authorizations for clinical studies, animal research regulations
Year:
2023
Region / City:
Not specified
Topic:
Thoracic esophagectomy, survival outcomes, esophageal cancer
Document Type:
Research article
Institution:
Not specified
Author:
Not specified
Target Audience:
Medical professionals, researchers in oncology
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Not specified
Topic:
Health-related quality of life after esophageal cancer treatment
Document Type:
Research Article
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Researchers, healthcare professionals, medical practitioners
Period of Application:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
Not specified
Region / Location:
Hypothetical / United States context implied
Topic:
Epidemiology, Nutritional and Environmental Risk Factors, Cancer Research
Document Type:
Educational Practice Problems
Institution / Organization:
Not specified
Author:
Not specified
Target Audience:
Students or trainees in epidemiology or public health
Study Designs Covered:
Cross-sectional, Prospective Cohort, Case-Control
Variables Analyzed:
Obesity status, Vegetable intake, Pesticide exposure, Alcohol consumption, Asthma, Esophageal cancer
Time Frame:
10-year follow-up for cohort study
Statistical Measures:
Measures of association, Odds ratio, p-value
Data Collection Method:
Self-report, Interviews
Limitations:
Potential biases and study design weaknesses discussed
Year:
2026
Region / City:
Not specified
Subject:
Oncology, Immunology
Document type:
Supplementary Figure
Institution:
Not specified
Authors:
Not specified
Target audience:
Researchers, Clinicians
Study focus:
CD8 densities and PD-L1 expression in small cell and esophageal carcinomas
Data type:
Quantitative immunohistochemical analysis
Tumor types:
Small cell lung carcinoma, small cell carcinoma of the prostate, small cell carcinoma of the bladder, small cell carcinoma of the esophagus, esophageal squamous cell carcinoma, esophageal adenocarcinoma
Measurement methods:
Immunohistochemistry, Tumor-infiltrating immune cells analysis